On February 14, 2018, the U.S. Food and Drug Administration (FDA) approved Janssen Therapeutics’ Erleada (apalutamide), a non-steroidal antiandrogen for... Read More
Skin cancer, colorectal cancer, prostate cancer or lymphoma sometimes occur after a heart transplant because of the immune suppressing drugs... Read More
A new study comparing the results of robot-assisted radical prostatectomy (RARP) to the current standard, open radical prostatectomy (ORP) has... Read More
A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy... Read More